A detailed history of Aqr Capital Management LLC transactions in Incyte Corp stock. As of the latest transaction made, Aqr Capital Management LLC holds 2,701,723 shares of INCY stock, worth $186 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
2,701,723
Previous 2,661,758 1.5%
Holding current value
$186 Million
Previous $161 Million 10.68%
% of portfolio
0.25%
Previous 0.25%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$57.33 - $68.61 $2.29 Million - $2.74 Million
39,965 Added 1.5%
2,701,723 $179 Million
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $56.4 Million - $70.2 Million
1,101,041 Added 70.55%
2,661,758 $161 Million
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $21.4 Million - $25.2 Million
378,004 Added 31.96%
1,560,717 $88.9 Million
Q4 2023

Feb 14, 2024

SELL
$52.16 - $64.19 $3.47 Million - $4.27 Million
-66,449 Reduced 5.32%
1,182,713 $74.3 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $17.8 Million - $20.3 Million
307,390 Added 32.64%
1,249,162 $72.2 Million
Q2 2023

Aug 14, 2023

BUY
$60.95 - $75.51 $5.81 Million - $7.2 Million
95,344 Added 11.26%
941,772 $58.6 Million
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $9.35 Million - $11.4 Million
133,109 Added 18.66%
846,428 $61.2 Million
Q4 2022

Feb 14, 2023

BUY
$67.18 - $84.11 $1.26 Million - $1.57 Million
18,720 Added 2.7%
713,319 $57.3 Million
Q3 2022

Nov 14, 2022

SELL
$66.18 - $82.86 $17.3 Million - $21.6 Million
-261,221 Reduced 27.33%
694,599 $46.3 Million
Q2 2022

Aug 15, 2022

BUY
$66.18 - $83.18 $6.73 Million - $8.46 Million
101,765 Added 11.92%
955,820 $71.7 Million
Q1 2022

May 16, 2022

BUY
$66.02 - $79.71 $25.9 Million - $31.3 Million
392,185 Added 84.91%
854,055 $67.8 Million
Q4 2021

Feb 14, 2022

BUY
$63.34 - $74.11 $10.6 Million - $12.4 Million
167,374 Added 56.83%
461,870 $33.9 Million
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $3.61 Million - $4.42 Million
52,593 Added 21.74%
294,496 $20.3 Million
Q2 2021

Aug 16, 2021

BUY
$79.87 - $87.53 $15.9 Million - $17.4 Million
199,284 Added 467.59%
241,903 $20.4 Million
Q1 2021

May 17, 2021

SELL
$76.02 - $100.5 $2.95 Million - $3.9 Million
-38,774 Reduced 47.64%
42,619 $3.46 Million
Q4 2020

Feb 16, 2021

SELL
$80.74 - $97.7 $4.06 Million - $4.91 Million
-50,301 Reduced 38.2%
81,393 $6.97 Million
Q3 2020

Nov 16, 2020

SELL
$85.07 - $109.69 $21.2 Million - $27.3 Million
-249,159 Reduced 65.42%
131,694 $11.8 Million
Q2 2020

Aug 17, 2020

SELL
$74.18 - $108.93 $131 Million - $192 Million
-1,765,225 Reduced 82.25%
380,853 $39.2 Million
Q1 2020

May 15, 2020

BUY
$63.18 - $85.97 $47.6 Million - $64.8 Million
753,967 Added 54.16%
2,146,078 $154 Million
Q4 2019

Feb 14, 2020

BUY
$73.04 - $95.72 $10.3 Million - $13.5 Million
140,766 Added 11.25%
1,392,111 $122 Million
Q3 2019

Nov 14, 2019

BUY
$72.82 - $86.52 $18.6 Million - $22.1 Million
255,541 Added 25.66%
1,251,345 $92.4 Million
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $11.2 Million - $13.5 Million
152,553 Added 18.09%
995,804 $83.5 Million
Q1 2019

May 14, 2019

BUY
$63.56 - $88.17 $17.6 Million - $24.4 Million
276,945 Added 48.9%
843,251 $72.5 Million
Q4 2018

Feb 14, 2019

SELL
$58.5 - $69.94 $1.67 Million - $1.99 Million
-28,485 Reduced 4.79%
566,306 $36 Million
Q3 2018

Nov 15, 2018

BUY
$61.75 - $74.23 $28.6 Million - $34.4 Million
462,965 Added 351.19%
594,791 $41.1 Million
Q2 2018

Aug 14, 2018

BUY
$60.85 - $83.98 $7.33 Million - $10.1 Million
120,414 Added 1055.15%
131,826 $8.83 Million
Q1 2018

May 15, 2018

SELL
$83.06 - $100.98 $1.02 Million - $1.24 Million
-12,274 Reduced 51.82%
11,412 $951,000
Q4 2017

Feb 14, 2018

SELL
$93.56 - $116.6 $715,359 - $891,523
-7,646 Reduced 24.4%
23,686 $2.24 Million
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $3.42 Million - $4.33 Million
31,332
31,332 $3.66 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.